Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts

S. D. Rowley, S. Piantadosi, D. C. Marcellus, R. J. Jones, N. E. Davidson, J. M. Davis, J. Kennedy, J. M. Wiley, J. R. Wingard, Andrew M Yeager, G. W. Santos

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

We previously described the predictive value of graft colony-forming units granulocyte macrophage (CFU-GM) content after 4-hydroperoxycyclophosphamide (4-HC) purging for the duration of aplasia after autologous bone marrow transplantation. Despite the uniform 4-HC concentration, we observed heterogeneity in CFU-GM survival and the kinetics of engraftment. We have now analysed patient and graft characteristics for 154 patients undergoing autologous transplantation with 4-HC purged grafts to further define this heterogeneity. Patients transplanted for the treatment of malignant lymphoma reached a peripheral blood granulocyte count of > 0.5 x 109/l (median, 20 versus 40 days; p < 0.001) and platelet transfusion independence (median, 30 versus 70 days; p < 0.001) significantly faster than patients transplanted for acute non-lymphoblastic leukemia. Other diagnostic groups were intermediate. These differences were independent of graft CFU-GM content. Multiple other patient and graft factors including patient age, peripheral blood counts on day of harvest, and amounts of other hematopoietic progenitors also predicted the kinetics of engraftment in univariate and multivariate analysis. Cytomegalovirus infection during the aplastic period predicted a delay in granulocyte (p = 0.024) but not platelet recovery (p = 0.174). This analysis demonstrates that multiple patient, graft, and post-transplant factors predict the engraftment capacity of autografts, and the kinetics of engraftment with 4-HC purged grafts. The multiple predictive factors explain a significant portion of the variability in engraftment kinetics observed after transplantation with 4-HC purged autografts.

Original languageEnglish (US)
Pages (from-to)183-191
Number of pages9
JournalBone Marrow Transplantation
Volume7
Issue number3
StatePublished - 1991
Externally publishedYes

Fingerprint

perfosfamide
Statistical Factor Analysis
Transplantation
Bone Marrow
Transplants
Granulocyte-Macrophage Progenitor Cells
Autologous Transplantation
Autografts
Granulocytes
Platelet Transfusion
Cytomegalovirus Infections
Bone Marrow Transplantation
Precursor Cell Lymphoblastic Leukemia-Lymphoma

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Rowley, S. D., Piantadosi, S., Marcellus, D. C., Jones, R. J., Davidson, N. E., Davis, J. M., ... Santos, G. W. (1991). Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts. Bone Marrow Transplantation, 7(3), 183-191.

Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts. / Rowley, S. D.; Piantadosi, S.; Marcellus, D. C.; Jones, R. J.; Davidson, N. E.; Davis, J. M.; Kennedy, J.; Wiley, J. M.; Wingard, J. R.; Yeager, Andrew M; Santos, G. W.

In: Bone Marrow Transplantation, Vol. 7, No. 3, 1991, p. 183-191.

Research output: Contribution to journalArticle

Rowley, SD, Piantadosi, S, Marcellus, DC, Jones, RJ, Davidson, NE, Davis, JM, Kennedy, J, Wiley, JM, Wingard, JR, Yeager, AM & Santos, GW 1991, 'Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts', Bone Marrow Transplantation, vol. 7, no. 3, pp. 183-191.
Rowley, S. D. ; Piantadosi, S. ; Marcellus, D. C. ; Jones, R. J. ; Davidson, N. E. ; Davis, J. M. ; Kennedy, J. ; Wiley, J. M. ; Wingard, J. R. ; Yeager, Andrew M ; Santos, G. W. / Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts. In: Bone Marrow Transplantation. 1991 ; Vol. 7, No. 3. pp. 183-191.
@article{2c079824830049f9a39ebec0e68655c9,
title = "Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts",
abstract = "We previously described the predictive value of graft colony-forming units granulocyte macrophage (CFU-GM) content after 4-hydroperoxycyclophosphamide (4-HC) purging for the duration of aplasia after autologous bone marrow transplantation. Despite the uniform 4-HC concentration, we observed heterogeneity in CFU-GM survival and the kinetics of engraftment. We have now analysed patient and graft characteristics for 154 patients undergoing autologous transplantation with 4-HC purged grafts to further define this heterogeneity. Patients transplanted for the treatment of malignant lymphoma reached a peripheral blood granulocyte count of > 0.5 x 109/l (median, 20 versus 40 days; p < 0.001) and platelet transfusion independence (median, 30 versus 70 days; p < 0.001) significantly faster than patients transplanted for acute non-lymphoblastic leukemia. Other diagnostic groups were intermediate. These differences were independent of graft CFU-GM content. Multiple other patient and graft factors including patient age, peripheral blood counts on day of harvest, and amounts of other hematopoietic progenitors also predicted the kinetics of engraftment in univariate and multivariate analysis. Cytomegalovirus infection during the aplastic period predicted a delay in granulocyte (p = 0.024) but not platelet recovery (p = 0.174). This analysis demonstrates that multiple patient, graft, and post-transplant factors predict the engraftment capacity of autografts, and the kinetics of engraftment with 4-HC purged grafts. The multiple predictive factors explain a significant portion of the variability in engraftment kinetics observed after transplantation with 4-HC purged autografts.",
author = "Rowley, {S. D.} and S. Piantadosi and Marcellus, {D. C.} and Jones, {R. J.} and Davidson, {N. E.} and Davis, {J. M.} and J. Kennedy and Wiley, {J. M.} and Wingard, {J. R.} and Yeager, {Andrew M} and Santos, {G. W.}",
year = "1991",
language = "English (US)",
volume = "7",
pages = "183--191",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts

AU - Rowley, S. D.

AU - Piantadosi, S.

AU - Marcellus, D. C.

AU - Jones, R. J.

AU - Davidson, N. E.

AU - Davis, J. M.

AU - Kennedy, J.

AU - Wiley, J. M.

AU - Wingard, J. R.

AU - Yeager, Andrew M

AU - Santos, G. W.

PY - 1991

Y1 - 1991

N2 - We previously described the predictive value of graft colony-forming units granulocyte macrophage (CFU-GM) content after 4-hydroperoxycyclophosphamide (4-HC) purging for the duration of aplasia after autologous bone marrow transplantation. Despite the uniform 4-HC concentration, we observed heterogeneity in CFU-GM survival and the kinetics of engraftment. We have now analysed patient and graft characteristics for 154 patients undergoing autologous transplantation with 4-HC purged grafts to further define this heterogeneity. Patients transplanted for the treatment of malignant lymphoma reached a peripheral blood granulocyte count of > 0.5 x 109/l (median, 20 versus 40 days; p < 0.001) and platelet transfusion independence (median, 30 versus 70 days; p < 0.001) significantly faster than patients transplanted for acute non-lymphoblastic leukemia. Other diagnostic groups were intermediate. These differences were independent of graft CFU-GM content. Multiple other patient and graft factors including patient age, peripheral blood counts on day of harvest, and amounts of other hematopoietic progenitors also predicted the kinetics of engraftment in univariate and multivariate analysis. Cytomegalovirus infection during the aplastic period predicted a delay in granulocyte (p = 0.024) but not platelet recovery (p = 0.174). This analysis demonstrates that multiple patient, graft, and post-transplant factors predict the engraftment capacity of autografts, and the kinetics of engraftment with 4-HC purged grafts. The multiple predictive factors explain a significant portion of the variability in engraftment kinetics observed after transplantation with 4-HC purged autografts.

AB - We previously described the predictive value of graft colony-forming units granulocyte macrophage (CFU-GM) content after 4-hydroperoxycyclophosphamide (4-HC) purging for the duration of aplasia after autologous bone marrow transplantation. Despite the uniform 4-HC concentration, we observed heterogeneity in CFU-GM survival and the kinetics of engraftment. We have now analysed patient and graft characteristics for 154 patients undergoing autologous transplantation with 4-HC purged grafts to further define this heterogeneity. Patients transplanted for the treatment of malignant lymphoma reached a peripheral blood granulocyte count of > 0.5 x 109/l (median, 20 versus 40 days; p < 0.001) and platelet transfusion independence (median, 30 versus 70 days; p < 0.001) significantly faster than patients transplanted for acute non-lymphoblastic leukemia. Other diagnostic groups were intermediate. These differences were independent of graft CFU-GM content. Multiple other patient and graft factors including patient age, peripheral blood counts on day of harvest, and amounts of other hematopoietic progenitors also predicted the kinetics of engraftment in univariate and multivariate analysis. Cytomegalovirus infection during the aplastic period predicted a delay in granulocyte (p = 0.024) but not platelet recovery (p = 0.174). This analysis demonstrates that multiple patient, graft, and post-transplant factors predict the engraftment capacity of autografts, and the kinetics of engraftment with 4-HC purged grafts. The multiple predictive factors explain a significant portion of the variability in engraftment kinetics observed after transplantation with 4-HC purged autografts.

UR - http://www.scopus.com/inward/record.url?scp=0026090244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026090244&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 183

EP - 191

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 3

ER -